Selected article for: "adverse event and limited adverse event"

Author: Matsuo, Keisuke; Ishiguro, Takashi; Najama, Takatomo; Shimizu, Yoshihiko; Kobayashi, Yasuhito; Mutou, Makoto
Title: Nivolumab-induced Myocarditis Successfully Treated with Corticosteroid Therapy: A Case Report and Review of the Literature
  • Document date: 2019_5_22
  • ID: y2n9z5sd_14
    Snippet: In conclusion, we experienced a case of nivolumabinduced myocarditis successfully treated with steroid therapy. We evaluated the CMR findings in the acute phase and after discharge. Although reports of nivolumab-induced myocarditis are limited, myocarditis is a life-threatening adverse event, and clinicians should consider it in the differential diagnosis when it is encountered in patients treated with nivolumab......
    Document: In conclusion, we experienced a case of nivolumabinduced myocarditis successfully treated with steroid therapy. We evaluated the CMR findings in the acute phase and after discharge. Although reports of nivolumab-induced myocarditis are limited, myocarditis is a life-threatening adverse event, and clinicians should consider it in the differential diagnosis when it is encountered in patients treated with nivolumab.

    Search related documents:
    Co phrase search for related documents
    • acute phase and clinician differential diagnosis consider: 1
    • acute phase and differential diagnosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute phase and differential diagnosis consider: 1, 2
    • acute phase and steroid therapy: 1, 2
    • adverse event and differential diagnosis: 1, 2
    • adverse event and steroid therapy: 1, 2
    • clinician differential diagnosis consider and differential diagnosis: 1
    • clinician differential diagnosis consider and differential diagnosis consider: 1
    • differential diagnosis and steroid therapy: 1, 2, 3, 4, 5, 6, 7